10-Q Filing

ENZON PHARMACEUTICALS, INC. CIK: 727510 Q1 2015

Filing Information

Form Type	10-Q
Accession Number	`0001144204-15-029931`
Period End Date	20150331
Filing Date	20150513
Fiscal Year	2015
Fiscal Period	Q1
XBRL Instance	enzn-20150331.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 52 Income Statement 30 Cash Flow Statement 30

Balance Sheet 52 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	3.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	3.00M	shares	Point-in-time
Cash	`Cash`	$34.80M	USD	Point-in-time
Cash	`Cash`	$34.56M	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Other current assets	`OtherAssetsCurrent`	$483.00K	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$478.00K	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Total current assets	`AssetsCurrent`	$35.29M	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Total current assets	`AssetsCurrent`	$35.04M	USD	Point-in-time
Deferred tax assets	`DeferredTaxAssetsLiabilitiesNetNoncurrent`	$2.54M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	170.00M	shares	Point-in-time
Deferred tax assets	`DeferredTaxAssetsLiabilitiesNetNoncurrent`	-	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	170.00M	shares	Point-in-time
Total assets	`Assets`	$35.04M	USD	Point-in-time
Total assets	`Assets`	$37.83M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	44.18M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	44.17M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	44.17M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	44.18M	shares	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$181.00K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$241.00K	USD	Point-in-time
Accrued expenses and other current liabilities	`AccruedLiabilitiesCurrent`	$468.00K	USD	Point-in-time
Accrued expenses and other current liabilities	`AccruedLiabilitiesCurrent`	$458.00K	USD	Point-in-time
Accrued dividends payable	`DividendsPayableCurrent`	-	USD	Point-in-time
Accrued dividends payable	`DividendsPayableCurrent`	$4.42M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$5.06M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$709.00K	USD	Point-in-time
Accrued rent liability	`AccruedRentNoncurrent`	$351.00K	USD	Point-in-time
Accrued rent liability	`AccruedRentNoncurrent`	$381.00K	USD	Point-in-time
Total liabilities	`Liabilities`	$5.44M	USD	Point-in-time
Total liabilities	`Liabilities`	$1.06M	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock - $.01 par value, authorized 3,000,000 shares; no shares issued and outstanding at March 31, 2015 and December 31, 2014	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock - $.01 par value, authorized 3,000,000 shares; no shares issued and outstanding at March 31, 2015 and December 31, 2014	`PreferredStockValue`	-	USD	Point-in-time
Common stock - $.01 par value, authorized 170,000,000 shares; issued and outstanding 44,182,414 shares at March 31, 2015 and 44,174,456 shares at December 31, 2014	`CommonStockValue`	$441.00K	USD	Point-in-time
Common stock - $.01 par value, authorized 170,000,000 shares; issued and outstanding 44,182,414 shares at March 31, 2015 and 44,174,456 shares at December 31, 2014	`CommonStockValue`	$441.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$130.06M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$130.06M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-93.73M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-100.90M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$36.77M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$29.60M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$37.83M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$35.04M	USD	Point-in-time

Income Statement 30 line items

Line Item	Tag	Value	Unit	Period
Royalties	`RoyaltyRevenue`	$8.94M	USD	1 Quarter
Royalties	`RoyaltyRevenue`	$5.21M	USD	1 Quarter
Miscellaneous income	`OtherSalesRevenueNet`	$56.00K	USD	1 Quarter
Miscellaneous income	`OtherSalesRevenueNet`	$31.00K	USD	1 Quarter
Total revenues	`SalesRevenueNet`	$8.97M	USD	1 Quarter
Total revenues	`SalesRevenueNet`	$5.26M	USD	1 Quarter
General and administrative	`OtherGeneralAndAdministrativeExpense`	$508.00K	USD	1 Quarter
General and administrative	`OtherGeneralAndAdministrativeExpense`	$583.00K	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$508.00K	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$583.00K	USD	1 Quarter
Operating income	`OperatingIncomeLoss`	$4.68M	USD	1 Quarter
Operating income	`OperatingIncomeLoss`	$8.47M	USD	1 Quarter
Other, net	`InvestmentIncomeNet`	-	USD	1 Quarter
Other, net	`InvestmentIncomeNet`	$109.00K	USD	1 Quarter
Total other income	`OtherNonoperatingIncomeExpense`	-	USD	1 Quarter
Total other income	`OtherNonoperatingIncomeExpense`	$109.00K	USD	1 Quarter
Income before income tax expense	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$8.58M	USD	1 Quarter
Income before income tax expense	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$4.68M	USD	1 Quarter
Income tax (benefit) expense	`IncomeTaxExpenseBenefit`	$55.00K	USD	1 Quarter
Income tax (benefit) expense	`IncomeTaxExpenseBenefit`	$-2.50M	USD	1 Quarter
Net income	`NetIncomeLoss`	$8.52M	USD	1 Quarter
Net income	`NetIncomeLoss`	$7.17M	USD	1 Quarter
Basic (in dollars per share)	`EarningsPerShareBasic`	$0.19	USD	1 Quarter
Basic (in dollars per share)	`EarningsPerShareBasic`	$0.16	USD	1 Quarter
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$0.19	USD	1 Quarter
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$0.16	USD	1 Quarter
Weighted-average shares outstanding - basic	`WeightedAverageNumberOfSharesOutstandingBasic`	44.09M	shares	1 Quarter
Weighted-average shares outstanding - basic	`WeightedAverageNumberOfSharesOutstandingBasic`	44.18M	shares	1 Quarter
Weighted-average shares outstanding - diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	44.23M	shares	1 Quarter
Weighted-average shares outstanding - diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	44.25M	shares	1 Quarter

Cash Flow Statement 30 line items

Line Item	Tag	Value	Unit	Period
Net income	`NetIncomeLoss`	$8.52M	USD	1 Quarter
Net income	`NetIncomeLoss`	$7.17M	USD	1 Quarter
Gain on disposal of fixed assets	`GainLossOnDispositionOfAssets`	-	USD	1 Quarter
Gain on disposal of fixed assets	`GainLossOnDispositionOfAssets`	$109.00K	USD	1 Quarter
Deferred tax benefit	`DeferredIncomeTaxExpenseBenefit`	$-2.50M	USD	1 Quarter
Deferred tax benefit	`DeferredIncomeTaxExpenseBenefit`	-	USD	1 Quarter
Changes in operating assets and liabilities	`IncreaseDecreaseInOtherOperatingCapitalNet`	$208.00K	USD	1 Quarter
Changes in operating assets and liabilities	`IncreaseDecreaseInOtherOperatingCapitalNet`	$10.00K	USD	1 Quarter
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$4.67M	USD	1 Quarter
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$8.20M	USD	1 Quarter
Proceeds from sales of fixed assets	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$146.00K	USD	1 Quarter
Proceeds from sales of fixed assets	`ProceedsFromSaleOfPropertyPlantAndEquipment`	-	USD	1 Quarter
Net cash provided by investing activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$146.00K	USD	1 Quarter
Net cash provided by investing activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	-	USD	1 Quarter
Withholding taxes - stock-based compensation	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$7.00K	USD	1 Quarter
Withholding taxes - stock-based compensation	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$6.00K	USD	1 Quarter
Common stock dividend	`PaymentsOfDividendsCommonStock`	-	USD	1 Quarter
Common stock dividend	`PaymentsOfDividendsCommonStock`	$4.42M	USD	1 Quarter
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$-7.00K	USD	1 Quarter
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$-4.42M	USD	1 Quarter
Net increase in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$8.34M	USD	1 Quarter
Net increase in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$242.00K	USD	1 Quarter
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$14.86M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$34.56M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$34.80M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$6.52M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$14.86M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$34.56M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$34.80M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$6.52M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.